submit to the journals

-Macular Oedema Journal Articles, Videos And Insights

-Macular Oedema:FEATURED Articles

flipper_slider

-Macular Oedema: Latest Articles

-Macular Oedema:FEATURED VIDEOS

Editor's choice

Francesco Boscia shares his thoughts on selecting the appropriate intravitreal anti-VEGF therapy and approach to patients who are not responding to treatment.
At WOC 2018, José Cunha-Vaz (University of Coimbra, Coimbra, Portugal) discussed his experience with treating patients with DME. The most significant developments in the area of DME are OCT imaging and the availability of anti-VEGF agents, which completely revolutionised treatment. The major issue is individualising treatment to each patient, as response varies greatly between different patients. The challenge is to understand how and which patients will respond to therapies. New drugs are currently on the horizon, which will offer new and better solutions to patients. Questions: 1. What have been the most significant recent developments in the area of DME? (1:02) 2. Discuss the current unmet needs and/or the challenges you face when treating patients with DME. (2:00) 3. What developments are you most excited about in the area of DME over the next few years? (3:20)

-Macular Oedema:Latest Videos

Video List based on Category on Node Page

Latest Videos

At WOC 2018, José Cunha-Vaz (University of Coimbra, Coimbra, Portugal) discussed his experience with treating patients with DME. The most significant developments in the area of DME are OCT imaging and the availability of anti-VEGF agents, which completely revolutionised treatment. The major...
Baruch Kuppermann discusses integrin peptide therapy and where it may fit within the current treatment regimen for patients with DME.
Francesco Boscia shares his thoughts on selecting the appropriate intravitreal anti-VEGF therapy and approach to patients who are not responding to treatment.
Hemal Mehta discusses the currently available intravitreal steroid therapies for the treatment of diabetic macular oedema and the supporting clinical trial and real-world evidence.
Albert Augustin discusses the use of anti-VEGF agents and intravitreal steroids in the treatment of diabetic macular edema.
Pravin Dugel discusses the unmet need in the treatment of neovascular AMD and the research into new agents, such as brolucizumab.

LATEST TWEETS

Conference Highlights